14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.05 $2.79 Tuesday, 23rd Apr 2024 FGEN stock ended at $1.07. This is 6.14% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 20.00% from a day low at $1.05 to a day high of $1.26.
90 days $0.85 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Feb 09, 2024 $2.40 $2.88 $2.34 $2.73 4 553 917
Feb 08, 2024 $2.16 $2.53 $2.08 $2.38 4 040 624
Feb 07, 2024 $1.91 $2.20 $1.81 $2.17 3 074 174
Feb 06, 2024 $2.00 $2.21 $1.85 $1.91 3 497 217
Feb 05, 2024 $1.81 $2.14 $1.80 $2.03 3 407 415
Feb 02, 2024 $2.38 $2.49 $1.72 $1.86 8 979 257
Feb 01, 2024 $1.87 $2.41 $1.73 $2.37 8 145 604
Jan 31, 2024 $1.75 $2.04 $1.58 $1.92 5 378 161
Jan 30, 2024 $1.80 $1.94 $1.51 $1.72 11 288 817
Jan 29, 2024 $0.91 $1.82 $0.88 $1.71 22 403 271
Jan 26, 2024 $1.16 $1.19 $0.93 $0.94 1 623 269
Jan 25, 2024 $0.98 $1.13 $0.96 $1.10 2 212 409
Jan 24, 2024 $0.90 $0.98 $0.85 $0.97 2 537 292
Jan 23, 2024 $0.89 $0.90 $0.83 $0.89 1 024 624
Jan 22, 2024 $0.775 $0.89 $0.775 $0.88 1 256 900
Jan 19, 2024 $0.82 $0.82 $0.760 $0.763 691 020
Jan 18, 2024 $0.760 $0.82 $0.760 $0.795 1 126 155
Jan 17, 2024 $0.740 $0.778 $0.735 $0.750 2 320 870
Jan 16, 2024 $0.730 $0.774 $0.730 $0.763 1 000 440
Jan 12, 2024 $0.85 $0.87 $0.730 $0.753 1 457 199
Jan 11, 2024 $0.88 $0.89 $0.782 $0.81 692 085
Jan 10, 2024 $0.89 $0.91 $0.82 $0.84 746 175
Jan 09, 2024 $0.80 $0.91 $0.775 $0.90 1 040 184
Jan 08, 2024 $0.764 $0.790 $0.703 $0.785 699 240
Jan 05, 2024 $0.733 $0.757 $0.696 $0.750 689 866
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT